863 related articles for article (PubMed ID: 26251238)
21. Is damage in central nervous system due to inflammation?
Chavarria A; Alcocer-Varela J
Autoimmun Rev; 2004 Jun; 3(4):251-60. PubMed ID: 15246020
[TBL] [Abstract][Full Text] [Related]
22. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
[TBL] [Abstract][Full Text] [Related]
23. Immune-mediated CNS damage.
Kierdorf K; Wang Y; Neumann H
Results Probl Cell Differ; 2010; 51():173-96. PubMed ID: 19130024
[TBL] [Abstract][Full Text] [Related]
24. How myeloid cells shape experimental autoimmune encephalomyelitis: At the crossroads of outside-in immunity.
Diebold M; Fehrenbacher L; Frosch M; Prinz M
Eur J Immunol; 2023 Oct; 53(10):e2250234. PubMed ID: 37505465
[TBL] [Abstract][Full Text] [Related]
25. Ontogeny and homeostasis of CNS myeloid cells.
Prinz M; Erny D; Hagemeyer N
Nat Immunol; 2017 Mar; 18(4):385-392. PubMed ID: 28323268
[TBL] [Abstract][Full Text] [Related]
26. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis.
Miller SD; McMahon EJ; Schreiner B; Bailey SL
Ann N Y Acad Sci; 2007 Apr; 1103():179-91. PubMed ID: 17376826
[TBL] [Abstract][Full Text] [Related]
27. Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease.
Codarri L; Greter M; Becher B
Trends Immunol; 2013 Mar; 34(3):114-9. PubMed ID: 23116549
[TBL] [Abstract][Full Text] [Related]
28. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD
J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774
[TBL] [Abstract][Full Text] [Related]
29. GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.
Croxford AL; Spath S; Becher B
Trends Immunol; 2015 Oct; 36(10):651-662. PubMed ID: 26431942
[TBL] [Abstract][Full Text] [Related]
30. CNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ.
Negi N; Das BK
Int Rev Immunol; 2018 Jan; 37(1):57-68. PubMed ID: 28961037
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA signature of central nervous system-infiltrating dendritic cells in an animal model of multiple sclerosis.
Hoye ML; Archambault AS; Gordon TM; Oetjen LK; Cain MD; Klein RS; Crosby SD; Kim BS; Miller TM; Wu GF
Immunology; 2018 Sep; 155(1):112-122. PubMed ID: 29749614
[TBL] [Abstract][Full Text] [Related]
32. The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis.
Chu F; Shi M; Zheng C; Shen D; Zhu J; Zheng X; Cui L
J Neuroimmunol; 2018 May; 318():1-7. PubMed ID: 29606295
[TBL] [Abstract][Full Text] [Related]
33. Regulation of immune cell entry into the central nervous system.
Engelhardt B
Results Probl Cell Differ; 2006; 43():259-80. PubMed ID: 17068976
[TBL] [Abstract][Full Text] [Related]
34. [MiRNAs: new actors in the physiopathology of multiple sclerosis].
Jagot F; Davoust N
Med Sci (Paris); 2017; 33(6-7):620-628. PubMed ID: 28990564
[TBL] [Abstract][Full Text] [Related]
35. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
36. Myeloid cells - targets of medication in multiple sclerosis.
Mishra MK; Yong VW
Nat Rev Neurol; 2016 Sep; 12(9):539-51. PubMed ID: 27514287
[TBL] [Abstract][Full Text] [Related]
37. Dendritic cells as therapeutic targets in neuroinflammation.
Luessi F; Zipp F; Witsch E
Cell Mol Life Sci; 2016 Jul; 73(13):2425-50. PubMed ID: 26970979
[TBL] [Abstract][Full Text] [Related]
38. Detection of microRNAs in microglia by real-time PCR in normal CNS and during neuroinflammation.
Veremeyko T; Starossom SC; Weiner HL; Ponomarev ED
J Vis Exp; 2012 Jul; (65):. PubMed ID: 22872097
[TBL] [Abstract][Full Text] [Related]
39. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
[TBL] [Abstract][Full Text] [Related]
40. Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.
Smith ME; Eller NL; McFarland HF; Racke MK; Raine CS
Am J Pathol; 1999 Oct; 155(4):1147-61. PubMed ID: 10514398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
